07.02.2012 08:42 Age: 2 yrs
Pfizer researchers contribute to SYNFACTS
Chemists from Pfizer USA take an active roll in the editorial process.
Thieme Chemistry would like to announce that the Heterocycles section in SYNFACTS now involves contributions from Pfizer organic and medicinal chemists!
We are pleased to say that the Pfizer team around Dr. Vincent Mascitti frequently reads SYNFACTS, our journal highlighting trends in synthetic organic chemistry, and approached SYNFACTS editor Victor Snieckus to get actively involved in it.
Read the Editorial of SYNFACTS issue 1, 2012 for further information
Access the first SYNFACTS contribution by Pfizer “Synthesis of Azabicyclo[3.1.1]heptane Derivatives from Cyclobutanones”